Literature DB >> 8401790

Regional cerebral blood flow in frontal lobe dementia of non-Alzheimer type.

J Risberg1, U Passant, S Warkentin, L Gustafson.   

Abstract

Twenty-five out of 26 cases of autopsy-verified frontal lobe degeneration of non-Alzheimer type (FLD) were found to have focal frontal or frontotemporal blood flow reductions involving both hemispheres. The deviant case had an asymmetric frontal pathology only apparent on the right side. Focal reduction of blood flow in the frontal lobes is, however, a common and unspecific flow abnormality found in e.g. Pick's disease. Creutzfeldt-Jakob's disease, and in some cases of Alzheimer's disease. Low frontal flow has also been reported in schizophrenia and in toxic encephalopathy. Since a characteristic feature of FLD is a steady progress of the pathology, serial flow measurements extending over several years are especially informative.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8401790     DOI: 10.1159/000107321

Source DB:  PubMed          Journal:  Dementia        ISSN: 1013-7424


  5 in total

Review 1.  Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-04       Impact factor: 10.154

2.  Brain atrophy in frontotemporal dementia.

Authors:  G B Frisoni; A Beltramello; C Geroldi; C Weiss; A Bianchetti; M Trabucchi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-08       Impact factor: 10.154

3.  Dementia lacking distinctive histopathology: clinicopathological evaluation of 32 cases.

Authors:  P Giannakopoulos; P R Hof; C Bouras
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

4.  Cortical hypermetabolism in MCI subjects: a compensatory mechanism?

Authors:  A Ashraf; Z Fan; D J Brooks; P Edison
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-09-30       Impact factor: 9.236

Review 5.  Frontotemporal lobar degeneration with TAR DNA-binding protein 43 (TDP-43): its journey of more than 100 years.

Authors:  Arenn F Carlos; Keith A Josephs
Journal:  J Neurol       Date:  2022-03-23       Impact factor: 6.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.